Genovate Biotechnology Co., Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Genovate Biotechnology Co., Limited with three other
companies in this sector in TAIWAN :
Sagittarius Life Science Corp.
sales of 438.72 million Taiwanese Dollars [US$14.95 million]
Tien Liang Biotech Co Ltd
(435.86 million Taiwanese Dollars [US$14.85 million]
UBI Pharma Inc
(479.56 million Taiwanese Dollars [US$16.34 million]
of which 80%
was Contract Medicine Manufacturing).
During the year ended December of 2019, sales at
Genovate Biotechnology Co., Limited were 465.76 million Taiwanese Dollars (US$15.87 million).
increase of 2.2%
versus 2018, when the company's sales were 455.80 million Taiwanese Dollars .
The sales level in 2019 was fairly close to the level five years ago: in 2014, Genovate Biotechnology Co., Limited had sales
of 475.45 million Taiwanese Dollars .
Sales of Agency saw an increase
that was more than double the company's growth rate: sales were up
51.1% in 2019, from
15.19 million Taiwanese Dollars to 22.94 million Taiwanese Dollars .
Not all segments of Genovate Biotechnology Co., Limited experienced an increase in sales in 2019:
sales of Other fell 84.6% to 278,000.00 Taiwanese Dollars .
(However, this segment's sales were only a very small portion of the company's overall sales).
Genovate Biotechnology Co., Limited also experienced decreases in sales in
Technical Service (down 67.5% to 3.91 million Taiwanese Dollars )